Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-propofol versus ketamine-sufentanil for procedural sedation and analgesia in children with acute lymphoblastic leukemia
IRCT20170809035601N6Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of ketamine, propofol and sufentanil in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Sedation level during procedure and Pain intensity during procedure. Started Mar 2016; status: completed.
02
Drugs
ketaminepropofolsufentanil
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20170809035601N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170809035601N6.